Not Yet Recruiting PHASE4 INTERVENTIONAL 2-arm
NCT07436182
Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. Metformin Monotherapy (MIRROR-DM)
Sponsor: Mansoura University
Conditions
Metformin Mitochondria
Interventions
Imeglimin Metformin 1000 mg Oral Tablet
Updated 1 time since 2026 Last updated: Feb 21, 2026 Started: Mar 1, 2026 Primary completion: Jun 1, 2026 Completion: Jun 1, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE4 clinical study on Metformin and Mitochondria, this trial is actively recruiting participants. The trial is conducted by Mansoura University and has accumulated 1 data snapshot since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Mansoura University
Data source: Mansoura University
For direct contact, visit the study record on ClinicalTrials.gov .